Aileron Therapeutics announced that Kathryn Gregory has been named Chief Business Officer (CBO). In this role, Ms. Gregory will head Aileron's business development efforts, including global licensing, collaborations, transactions and alliances. Most recently, Ms. Gregory was President of KG BioPharma Consulting LLC, where she assisted small and mid-size biopharma companies in a range of corporate strategy and business development activities.